Elan Competing Product. For the term of the Agreement, Elan shall not itself or through an Affiliate or Third Party commercialise or, develop in the Territory nor license another party in the Territory to commercialise or develop any other sustained release oral dosage form for prescription use in humans which contains the Compound or any Alternate Compound as an active ingredient for:
Appears in 7 contracts
Samples: License Agreement, License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)
